Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George(Dana-Farber Cancer Institute), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Scott L. Carter(Broad Institute), Dennis O. Adeegbe(Moffitt Cancer Center), Diana Miao(Broad Institute), Patrick A. Ott(Dana-Farber Cancer Institute), Catherine J. Wu(Dana-Farber Cancer Institute), Chandrajit P. Raut(Dana-Farber Cancer Institute), Scott J. Rodig(Brigham and Women's Hospital), George D. Demetri(Dana-Farber Cancer Institute), Ali Amin‐Mansour, Gordon J. Freeman(Dana-Farber Cancer Institute), Mikel Lipschitz(Brigham and Women's Hospital), Peter S. Hammerman(Broad Institute), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Kwok‐Kin Wong(NYU Langone Health)
Cited by 489
Related Papers
Comprehensive molecular profiling of lung adenocarcinoma
|Nature|2014|5.9k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k